Insider · CIK 0001913961

Habibizad Nazila

Reports to the SEC for 1 company · SOUTH SAN FRANCISCO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001913961

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2022-10-05	Global Blood Therapeutics, Inc.D Disposition to Issuer	See Remarks	DDisposition to Issuer	−39.7K sh	—	—	0
2022-10-05	Global Blood Therapeutics, Inc.Restricted Stock UnitsD Disposition to Issuer	See Remarks	DDisposition to Issuer	−938 sh	—	—	0
2022-10-05	Global Blood Therapeutics, Inc.Restricted Stock UnitsD Disposition to Issuer	See Remarks	DDisposition to Issuer	−2,750 sh	—	—	0
2022-10-05	Global Blood Therapeutics, Inc.Restricted Stock UnitsD Disposition to Issuer	See Remarks	DDisposition to Issuer	−1,746 sh	—	—	0
2022-10-05	Global Blood Therapeutics, Inc.Restricted Stock UnitsD Disposition to Issuer	See Remarks	DDisposition to Issuer	−548 sh	—	—	0
2022-10-05	Global Blood Therapeutics, Inc.Restricted Stock UnitsD Disposition to Issuer	See Remarks	DDisposition to Issuer	−8,353 sh	—	—	0
2022-10-05	Global Blood Therapeutics, Inc.Restricted Stock UnitsD Disposition to Issuer	See Remarks	DDisposition to Issuer	−15.5K sh	—	—	0
2022-10-05	Global Blood Therapeutics, Inc.Restricted Stock UnitsD Disposition to Issuer	See Remarks	DDisposition to Issuer	−26.5K sh	—	—	0
2022-10-05	Global Blood Therapeutics, Inc.Restricted Stock UnitsD Disposition to Issuer	See Remarks	DDisposition to Issuer	−6,300 sh	—	—	0
2022-10-05	Global Blood Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	See Remarks	DDisposition to Issuer	−5,995 sh	—	—	0
2022-10-05	Global Blood Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	See Remarks	DDisposition to Issuer	−5,957 sh	—	—	0
2022-10-05	Global Blood Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	See Remarks	DDisposition to Issuer	−4,448 sh	—	—	0
2022-10-05	Global Blood Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	See Remarks	DDisposition to Issuer	−7,917 sh	—	—	0
2022-10-05	Global Blood Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	See Remarks	DDisposition to Issuer	−3,724 sh	—	—	0
2022-10-05	Global Blood Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	See Remarks	DDisposition to Issuer	−2,329 sh	—	—	0
2022-10-05	Global Blood Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	See Remarks	DDisposition to Issuer	−23.4K sh	—	—	0
2022-10-05	Global Blood Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	See Remarks	DDisposition to Issuer	−28.6K sh	—	—	0
2022-10-01	Global Blood Therapeutics, Inc.M Exercise/Conversion	See Remarks	MExercise/Conversion	+1,375 sh	—	—	39,498
2022-10-01	Global Blood Therapeutics, Inc.M Exercise/Conversion	See Remarks	MExercise/Conversion	+182 sh	—	—	39,680
2022-10-01	Global Blood Therapeutics, Inc.Restricted Stock UnitsM Exercise/Conversion	See Remarks	MExercise/Conversion	−1,375 sh	—	—	2,750
2022-10-01	Global Blood Therapeutics, Inc.Restricted Stock UnitsM Exercise/Conversion	See Remarks	MExercise/Conversion	−182 sh	—	—	548
2022-09-29	Global Blood Therapeutics, Inc.G Gift	See Remarks	GGift	−3,500 sh	—	—	38,123
2022-09-27	Global Blood Therapeutics, Inc.M Exercise/Conversion	See Remarks	MExercise/Conversion	+23.6K sh	$12.95	+$306K	35,465
2022-09-27	Global Blood Therapeutics, Inc.M Exercise/Conversion	See Remarks	MExercise/Conversion	+3,005 sh	$29.75	+$89.4K	38,470
2022-09-27	Global Blood Therapeutics, Inc.M Exercise/Conversion	See Remarks	MExercise/Conversion	+2,043 sh	$59.60	+$122K	40,513
2022-09-27	Global Blood Therapeutics, Inc.M Exercise/Conversion	See Remarks	MExercise/Conversion	+1,027 sh	$48.44	+$49.7K	41,540
2022-09-27	Global Blood Therapeutics, Inc.M Exercise/Conversion	See Remarks	MExercise/Conversion	+83 sh	$46.99	+$3,900.17	41,623
2022-09-27	Global Blood Therapeutics, Inc.Stock Option (Right to Buy)M Exercise/Conversion	See Remarks	MExercise/Conversion	−23.6K sh	—	—	0
2022-09-27	Global Blood Therapeutics, Inc.Stock Option (Right to Buy)M Exercise/Conversion	See Remarks	MExercise/Conversion	−3,005 sh	—	—	5,995
2022-09-27	Global Blood Therapeutics, Inc.Stock Option (Right to Buy)M Exercise/Conversion	See Remarks	MExercise/Conversion	−2,043 sh	—	—	5,957
2022-09-27	Global Blood Therapeutics, Inc.Stock Option (Right to Buy)M Exercise/Conversion	See Remarks	MExercise/Conversion	−1,027 sh	—	—	4,448
2022-09-27	Global Blood Therapeutics, Inc.Stock Option (Right to Buy)M Exercise/Conversion	See Remarks	MExercise/Conversion	−83 sh	—	—	7,917
2022-09-01	Global Blood Therapeutics, Inc.M Exercise/Conversion	See Remarks	MExercise/Conversion	+1,670 sh	—	—	11,002
2022-09-01	Global Blood Therapeutics, Inc.M Exercise/Conversion	See Remarks	MExercise/Conversion	+2,208 sh	—	—	13,210
2022-09-01	Global Blood Therapeutics, Inc.F Tax Payment	See Remarks	FTax Payment	−1,342 sh	$68.15	−$91.5K	11,868
2022-09-01	Global Blood Therapeutics, Inc.Restricted Stock UnitsM Exercise/Conversion	See Remarks	MExercise/Conversion	−1,670 sh	—	—	8,353
2022-09-01	Global Blood Therapeutics, Inc.Restricted Stock UnitsM Exercise/Conversion	See Remarks	MExercise/Conversion	−2,208 sh	—	—	15,460
2022-08-31	Global Blood Therapeutics, Inc.A Award	See Remarks	AAward	+414 sh	$25.37	+$10.5K	9,332
2022-08-18	Global Blood Therapeutics, Inc.S Sale	See Remarks	SSale	−4,678 sh	$67.19	−$314K	8,918
2022-08-01	Global Blood Therapeutics, Inc.M Exercise/Conversion	See Remarks	MExercise/Conversion	+1,518 sh	—	—	14,122
2022-08-01	Global Blood Therapeutics, Inc.F Tax Payment	See Remarks	FTax Payment	−526 sh	$32.40	−$17K	13,596
2022-08-01	Global Blood Therapeutics, Inc.Restricted Stock UnitsM Exercise/Conversion	See Remarks	MExercise/Conversion	−937 sh	—	—	938
2022-08-01	Global Blood Therapeutics, Inc.Restricted Stock UnitsM Exercise/Conversion	See Remarks	MExercise/Conversion	−581 sh	—	—	1,746
2022-04-01	Global Blood Therapeutics, Inc.M Exercise/Conversion	See Remarks	MExercise/Conversion	+1,558 sh	—	—	30,576
2022-04-01	Global Blood Therapeutics, Inc.F Tax Payment	See Remarks	FTax Payment	−540 sh	$35.91	−$19.4K	30,036
2022-04-01	Global Blood Therapeutics, Inc.Restricted Stock UnitsM Exercise/Conversion	See Remarks	MExercise/Conversion	−1,375 sh	—	—	4,125
2022-04-01	Global Blood Therapeutics, Inc.Restricted Stock UnitsM Exercise/Conversion	See Remarks	MExercise/Conversion	−183 sh	—	—	730
2022-03-01	Global Blood Therapeutics, Inc.M Exercise/Conversion	See Remarks	MExercise/Conversion	+1,671 sh	—	—	29,631
2022-03-01	Global Blood Therapeutics, Inc.F Tax Payment	See Remarks	FTax Payment	−613 sh	$29.87	−$18.3K	29,018
2022-03-01	Global Blood Therapeutics, Inc.Restricted Stock UnitsM Exercise/Conversion	See Remarks	MExercise/Conversion	−1,671 sh	—	—	10,023

Recent filings

Accepted (ET)
Oct 64
Habibizad Nazila0000899243-22-033147
SEC(opens sec.gov)
Oct 44
Habibizad Nazila0000899243-22-032687
SEC(opens sec.gov)

Companies

Global Blood Therapeutics, Inc.See Remarks

Address

C/O GLOBAL BLOOD THERAPEUTICS, INC. 181 OYSTER POINT BLVD.

SOUTH SAN FRANCISCO, CA, 94080